Tandem Corp (TNDM) Long-Term Liabilities to Equity

Corporate emblem and logo of Tandem Corp (TNDM)

Tandem Diabetes Care (TNDM) is establishing precision delivery of pump components, utilizing assembly diversification to maintain high margins. Revenues are based on the sale of sensor devices and consumables for patients with diabetes. Market price action (separate_debt_long_eq) captures the 5.53 metric. Stable demand and demographics provide the business with defensive qualities, completely neutralizing the impact of macroeconomic risks on future results.

TNDM Tandem Diabetes: Long-Term Debt to Capital in the range 07/04/2022 - 11/01/2026
Manufactured product of Tandem Diabetes Care

When constructing a long-term portfolio, it is critical to exclude issuers with excessive leverage to minimize default risks. The ratio of long-term liabilities to equity determines the degree of financial autonomy for Tandem Diabetes Care (TNDM), allowing for an assessment of whether the development of Control-IQ innovations and AI integration is funded by internal resources rather than external loans, which is clearly reflected in the trend of long-term debt to equity.

Key competitors

Boston Scientific Corp (BSX) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Edwards Lifesciences Corp (EW)|RMD: Long-Term Liabilities to Equity|Long-Term Debt to Capital PODD (Insulet Corporation)|Zimmer (ZBH) - Long-Term Liabilities to Capital|CooperCompanies - Long-Term Debt to Capital|Invisalign (ALGN) - Long-Term Debt to Equity Ratio|GMED: Long-Term Debt to Capital|TMDX - Ratio of Long-Term Indebtedness to Capital|ATEC (Alphatec Holdings, Inc.) - Long-Term Debt to Capital|Long-Term Debt to Capital artivion.com|Long-Term Debt to Equity Enovis (ENOV)|Long-Term Debt to Equity IART (Integra LifeSciences Corp)|Long-Term Debt to Capital ESTA (Motiva)|Ratio of Long-Term Indebtedness to Capital iLet Bionic Pancreas (BBNX)|IRMD: Long-Term Debt to Equity Ratio|Long-Term Liabilities to Equity EMBC|AXGN: Long-Term Debt to Capital|Long-Term Liabilities to Capital SI-BONE Inc (SIBN)|OFIX (Orthofix International) - Long-Term Debt to Capital|Long-Term Debt to Capital Ratio BVS (Bioventus Global)|Long-Term Debt to Equity Ratio KIDS (OrthoPediatrics Corp.)|TMCI (treace.com) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Equity Strata Critical Medical SRTA|CARL - Long-Term Debt to Equity Ratio|RxSight Corp - Long-Term Debt to Capital|Long-Term Liabilities to Capital ClearPoint Neuro, Inc.|STXS: Long-Term Debt to Capital|Long-Term Debt to Capital Ratio STIM|SGHT (Sight Sciences) - Long-Term Debt to Capital|Orchestra BioMed Inc. (OBIO) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Capital ANIK|Long-Term Debt to Equity Ratio InspireMD Inc. NSPR|Long-Term Debt to Capital ZJYL (Jin Medical)|Long-Term Debt to Capital Vivani Medical Inc VANI|XTNT - Long-Term Debt to Equity|NMTC: Long-Term Debt to Equity|MODD (modular-medical.com) - Long-Term Debt to Equity Ratio|Myomo Inc - Long-Term Debt to Capital Coefficient|COCH (Envoy Medical, Inc.) - Long-Term Debt to Capital|Long-Term Liabilities to Capital vivoslife.com VVOS|Long-Term Debt to Equity enVVeno Medical Corp. (NVNO)|sintx.com (SINT) - Long-Term Indebtedness to Equity|Tenon Medical, Inc - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Lifeward Ltd. LFWD|Autonomix - Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital invobioscience.com IVF|Bone Biologics Corp (BBLG) - Long-Term Debt to Equity|Long-Term Liabilities to Equity AXNX (Axonics Inc.)|Long-Term Debt to Equity Biolase, Inc.|Long-Term Debt to Equity Ratio Dynatronics Corp. (DYNT)|Long-Term Debt to Capital FNA|INVO - Long-Term Liabilities to Capital